In this discussion, we will address some of the issues around precision prevention from the perspectives of different stakeholders, with the aim of publishing a position paper in this area. This session is online and free to attend, and we hope this will be of interest to individuals from healthcare, academia, industry and regulators, as well as members of the public.
Modulation of receptors and their intracellular signalling events continues to be a highly lucrative strategy for the discovery of novel therapeutics. However, the approaches used to modulate these targets have become much more varied in recent years. In this meeting we will discuss the new therapeutic modalities that are transforming our ability to pharmacologically modulate receptors and their intracellular signalling pathways.
The BPS is pleased to be supporting a member-led symposium at this event, entitled 'Utilising Clinical Pharmacology Approaches to Optimise Childhood Cancer Treatment'.
The BPS will be delivering a joint workshop with The Physiological Society at the BNA Festival of Neuroscience 2025. The workshop will explore the question 'how do we make breakthroughs in treating neurodegeneration?'.
Hosted by the European Atherosclerosis Society (EAS) and the British Atherosclerosis Society (BAS). The BPS are running a workshop on Lp(a) at this conference, delivered by Anne Langsted and Jamini Cegla.
At UK Pharmacogenetics & Stratified Medicine Network (UKPGx) 12th Annual Open Meeting (UKPGx2025) you will hear about the latest developments in the field of pharmacogenetics and stratified medicine. Multidisciplinary experts will come together to review, and offer solutions to, the challenges facing the adoption of genomic medicine into the clinic.
The BPS is delighted to announce that we will be bringing our next annual conference - Pharmacology 2025 - to the ICC Belfast from 16 - 18 December 2025!
.png.aspx)
.png)
